A bitter pill as China crackdowns squeeze pharma margins
May 24, 2014 at 22:00 PM EDT
SHANGHAI, May 25 (Reuters) - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over.